Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease.
A clinically-related animal model of Parkinson's disease (PD) may enable the elucidation of the etiology of the disease and assist the development of medications. However, none of the current neurotoxin-based models recapitulates the main clinical features of the disease or the pathological hal...
Main Authors: | Nian Xiong, Jinsha Huang, Zhentao Zhang, Zhaowen Zhang, Jing Xiong, Xingyuan Liu, Min Jia, Fang Wang, Chunnuan Chen, Xuebing Cao, Zhihou Liang, Shenggang Sun, Zhicheng Lin, Tao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-11-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2774159?pdf=render |
Similar Items
-
Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.
by: Nian Xiong, et al.
Published: (2011-01-01) -
Cell cycle regulation of DNA polymerase beta in rotenone-based Parkinson's disease models.
by: Hongcai Wang, et al.
Published: (2014-01-01) -
7,8-Dihydroxyflavone Protects Nigrostriatal Dopaminergic Neurons from Rotenone-Induced Neurotoxicity in Rodents
by: Shuke Nie, et al.
Published: (2019-01-01) -
Glucocerebrosidase L444P mutation confers genetic risk for Parkinson’s disease in central China
by: Wang Youpei, et al.
Published: (2012-12-01) -
Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population.
by: Ling Liu, et al.
Published: (2015-01-01)